ARLINGTON, Va., Jan. 13 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers. As lab budgets remain constricted, pharmaceutical and biotech labs are outsourcing pre-clinical and drug discovery services to create efficiency and offload the need to maintain staff, instruments and consumables for irregularly scheduled projects and projects that extend beyond their scope. This report was designed to provide guidance to the life science supplier as to the relationship between the pharmaceutical/biotech industries and Contract Research Organizations (CROs) -- and how capitalizing on fluctuations in outsourcing, the types of projects and tools purchased represents an opportunity that can steadily impact revenues.
The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers, includes detailed responses from over 100 scientists from CROs and over 100 scientists from Industry labs outsourcing to CROs to understand buying habits, criteria for making decisions, current vendors and purchases planned for 2010. Suppliers can use this report to characterize the potential of the preclinical CRO market, project the size and share of the CRO market for both consumables and instrumentation for 2010, and identify opportunities for capturing CRO market share.
Thermo Fisher Scientific
Agilent Technologies
BD Biosciences
Bio-Rad
Beckman Coulter
Life Technologies
Millipore
GE Healthcare
PerkinElmer
Qiagen
Roche Applied Science
Sigma-Aldrich
Waters Corporation
To learn more about this report, a complimentary Executive Summary is available at http://www.gene2drug.com/reports/206/.
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC
